The FDA is freeing Intellia’s…
The FDA is freeing Intellia’s CRISPR therapy from one of [...]
Ahead of its acquisition by cancer…
Ahead of its acquisition by cancer imaging company Kuva Labs, [...]
Four years after listing on the…
Four years after listing on the Nasdaq, Genenta Sciences is [...]
What do you get when you insert a…
What do you get when you insert a molecular glue [...]
Former CytoDyn CEO Nader…
Former CytoDyn CEO Nader Pourhassan, Ph.D., has received a 30-month [...]
AstraZeneca is showing no signs of…
AstraZeneca is showing no signs of restarting a 200 million [...]
As the Trump administration erodes…
As the Trump administration erodes U.S. infrastructure supporting infectious disease [...]
Sanofi has reported mixed phase 3…
Sanofi has reported mixed phase 3 data on amlitelimab, further [...]
Bristol Myers Squibb added a big…
Bristol Myers Squibb added a big name to its executive [...]
Hoth Therapeutics has shared phase…
Hoth Therapeutics has shared phase 2 results on its treatment [...]